O
PAHC icon

OppenheimerFunds’s Phibro Animal Health PAHC Stock Holding History

OppenheimerFunds’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$512K Buy
15,507
+2,660
+21% +$82.8K ﹤0.01% 1360
2018
Q4 		$413K Buy
12,847
+615
+5% +$23.2K ﹤0.01% 1441
2018
Q3 		$525K Buy
12,232
+1,515
+14% +$71.6K ﹤0.01% 1426
2018
Q2 		$494K Sell
10,717
-1,685
-14% -$74.6K ﹤0.01% 1431
2018
Q1 		$492K Sell
12,402
-3,279
-21% -$121K ﹤0.01% 1404
2017
Q4 		$525K Buy
15,681
+703
+5% +$25K ﹤0.01% 1491
2017
Q3 		$554K Sell
14,978
-1,857
-11% -$69.7K ﹤0.01% 1476
2017
Q2 		$624K Sell
16,835
-3,939
-19% -$129K ﹤0.01% 1398
2017
Q1 		$583K Buy
20,774
+3,903
+23% +$110K ﹤0.01% 1438
2016
Q4 		$494K Buy
16,871
+3,526
+26% +$96.2K ﹤0.01% 1390
2016
Q3 		$363K Sell
13,345
-5,302
-28% -$120K ﹤0.01% 1417
2016
Q2 		$348K Buy
18,647
+6,145
+49% +$128K ﹤0.01% 1398
2016
Q1 		$338K Buy
12,502
+652
+6% +$18.7K ﹤0.01% 1401
2015
Q4 		$357K Buy
+11,850
New +$380K ﹤0.01% 1440

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

OppenheimerFunds's PAHC Position: Q1 2019 in Review

OppenheimerFunds increased its Phibro Animal Health (PAHC) stake by 21% in Q1 2019, buying an estimated $82.8K and bringing the position to 15,507 shares worth $512K. The position accounts for ﹤0.01% of the portfolio, ranked #1360.

OppenheimerFunds first reported a position in PAHC in Q4 2015 and has held it in 14 quarters since. The position peaked at $624K in Q2 2017. 176 funds tracked by Wall St. Rank hold PAHC as of Q1 2019.

  • OppenheimerFunds held 15,507 shares of Phibro Animal Health worth $512K as of Q1 2019.
  • OppenheimerFunds bought 2,660 Phibro Animal Health shares in Q1 2019, an estimated $82.8K.
  • Phibro Animal Health made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1360 holding.
  • OppenheimerFunds first reported a position in Phibro Animal Health in Q4 2015 and has held it in 14 quarters since.
  • OppenheimerFunds's Phibro Animal Health position peaked at $624K in Q2 2017.
  • 176 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.